My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 74

    1.

    A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck.

    Gilbert J, Rudek MA, Higgins MJ, Zhao M, Bienvenu S, Tsottles N, Wahl R, Forastiere A, Gillison M.

    Clin Cancer Res. 2012 Mar 15;18(6):1735-42. Epub 2012 Jan 23.

    PMID:
    22271880
    [PubMed - in process]

    Related citations

    2.

    A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neck.

    Lewis CM, Glisson BS, Feng L, Wan F, Tang X, Wistuba II, El-Naggar AK, Rosenthal DI, Chambers MS, Lustig RA, Weber RS.

    Clin Cancer Res. 2012 Mar 1;18(5):1435-46. Epub 2012 Jan 18.

    PMID:
    22261807
    [PubMed - in process]

    Related citations

    3.

    Prospective trial of synchronous bevacizumab, erlotinib, and concurrent chemoradiation in locally advanced head and neck cancer.

    Yoo DS, Kirkpatrick JP, Craciunescu O, Broadwater G, Peterson BL, Carroll MD, Clough R, MacFall JR, Hoang J, Scher RL, Esclamado RM, Dunphy FR, Ready NE, Brizel DM.

    Clin Cancer Res. 2012 Mar 1;18(5):1404-14. Epub 2012 Jan 17.

    PMID:
    22253412
    [PubMed - in process]

    Related citations

    4.

    Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival.

    Gubanova E, Brown B, Ivanov SV, Helleday T, Mills GB, Yarbrough WG, Issaeva N.

    Clin Cancer Res. 2012 Mar 1;18(5):1257-67. Epub 2012 Jan 13.

    PMID:
    22247495
    [PubMed - in process]

    Related citations

    5.

    Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elements.

    Hayes DN, Lucas AS, Tanvetyanon T, Krzyzanowska MK, Chung CH, Murphy BA, Gilbert J, Mehra R, Moore DT, Sheikh A, Hoskins J, Hayward MC, Zhao N, O'Connor W, Weck KE, Cohen RB, Cohen EE.

    Clin Cancer Res. 2012 Apr 1;18(7):2056-65. Epub 2012 Jan 12.

    PMID:
    22241789
    [PubMed - in process]

    Related citations

    6.

    Epidermal growth factor receptor protein detection in head and neck cancer patients: a many-faceted picture.

    Thariat J, Etienne-Grimaldi MC, Grall D, Bensadoun RJ, Cayre A, Penault-Llorca F, Veracini L, Francoual M, Formento JL, Dassonville O, De Raucourt D, Geoffrois L, Giraud P, Racadot S, Morinière S, Milano G, Van Obberghen-Schilling E.

    Clin Cancer Res. 2012 Mar 1;18(5):1313-22. Epub 2012 Jan 6.

    PMID:
    22228639
    [PubMed - in process]

    Related citations

    7.

    Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer.

    Sun W, Zaboli D, Wang H, Liu Y, Arnaoutakis D, Khan T, Khan Z, Koch WM, Califano JA.

    Clin Cancer Res. 2012 Feb 15;18(4):1082-91. Epub 2012 Jan 6.

    PMID:
    22228635
    [PubMed - in process]

    Related citations

    8.

    Prognostic significance of plasma osteopontin in patients with locoregionally advanced head and neck squamous cell carcinoma treated on TROG 02.02 phase III trial.

    Lim AM, Rischin D, Fisher R, Cao H, Kwok K, Truong D, McArthur GA, Young RJ, Giaccia A, Peters L, Le QT.

    Clin Cancer Res. 2012 Jan 1;18(1):301-7. Epub 2011 Nov 17.

    PMID:
    22096023
    [PubMed - indexed for MEDLINE]

    Related citations

    9.

    TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.

    Skinner HD, Sandulache VC, Ow TJ, Meyn RE, Yordy JS, Beadle BM, Fitzgerald AL, Giri U, Ang KK, Myers JN.

    Clin Cancer Res. 2012 Jan 1;18(1):290-300. Epub 2011 Nov 16.

    PMID:
    22090360
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis.

    Bhattacharya A, Roy R, Snijders AM, Hamilton G, Paquette J, Tokuyasu T, Bengtsson H, Jordan RC, Olshen AB, Pinkel D, Schmidt BL, Albertson DG.

    Clin Cancer Res. 2011 Nov 15;17(22):7024-34. Epub 2011 Nov 8.

    PMID:
    22068658
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer.

    Sano D, Xie TX, Ow TJ, Zhao M, Pickering CR, Zhou G, Sandulache VC, Wheeler DA, Gibbs RA, Caulin C, Myers JN.

    Clin Cancer Res. 2011 Nov 1;17(21):6658-70. Epub 2011 Sep 8.

    PMID:
    21903770
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Significance of dysregulated metadherin and microRNA-375 in head and neck cancer.

    Hui AB, Bruce JP, Alajez NM, Shi W, Yue S, Perez-Ordonez B, Xu W, O'Sullivan B, Waldron J, Cummings B, Gullane P, Siu L, Liu FF.

    Clin Cancer Res. 2011 Dec 15;17(24):7539-50. Epub 2011 Oct 26.

    PMID:
    22031094
    [PubMed - in process]

    Related citations

    13.

    Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo.

    Chang KY, Tsai SY, Wu CM, Yen CJ, Chuang BF, Chang JY.

    Clin Cancer Res. 2011 Nov 15;17(22):7116-26. Epub 2011 Oct 5.

    PMID:
    21976531
    [PubMed - indexed for MEDLINE]

    Related citations

    14.

    Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination.

    Schache AG, Liloglou T, Risk JM, Filia A, Jones TM, Sheard J, Woolgar JA, Helliwell TR, Triantafyllou A, Robinson M, Sloan P, Harvey-Woodworth C, Sisson D, Shaw RJ.

    Clin Cancer Res. 2011 Oct 1;17(19):6262-71.

    PMID:
    21969383
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    15.

    High XRCC1 protein expression is associated with poorer survival in patients with head and neck squamous cell carcinoma.

    Ang MK, Patel MR, Yin XY, Sundaram S, Fritchie K, Zhao N, Liu Y, Freemerman AJ, Wilkerson MD, Walter V, Weissler MC, Shockley WW, Couch ME, Zanation AM, Hackman T, Chera BS, Harris SL, Miller CR, Thorne LB, Hayward MC, Funkhouser WK, Olshan AF, Shores CG, Makowski L, Hayes DN.

    Clin Cancer Res. 2011 Oct 15;17(20):6542-52. Epub 2011 Sep 9.

    PMID:
    21908577
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    Curcumin treatment suppresses IKKβ kinase activity of salivary cells of patients with head and neck cancer: a pilot study.

    Kim SG, Veena MS, Basak SK, Han E, Tajima T, Gjertson DW, Starr J, Eidelman O, Pollard HB, Srivastava M, Srivatsan ES, Wang MB.

    Clin Cancer Res. 2011 Sep 15;17(18):5953-61. Epub 2011 Aug 5.

    PMID:
    21821700
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C₁₈-ceramide as a novel biomarker for monitoring response.

    Saddoughi SA, Garrett-Mayer E, Chaudhary U, O'Brien PE, Afrin LB, Day TA, Gillespie MB, Sharma AK, Wilhoit CS, Bostick R, Senkal CE, Hannun YA, Bielawski J, Simon GR, Shirai K, Ogretmen B.

    Clin Cancer Res. 2011 Sep 15;17(18):6097-105. Epub 2011 Jul 26.

    PMID:
    21791630
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    Population analysis of erlotinib in adults and children reveals pharmacokinetic characteristics as the main factor explaining tolerance particularities in children.

    White-Koning M, Civade E, Geoerger B, Thomas F, Le Deley MC, Hennebelle I, Delord JP, Chatelut E, Vassal G.

    Clin Cancer Res. 2011 Jul 15;17(14):4862-71. Epub 2011 Jun 8.

    PMID:
    21653689
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer.

    Argiris A, Duffy AG, Kummar S, Simone NL, Arai Y, Kim SW, Rudy SF, Kannabiran VR, Yang X, Jang M, Chen Z, Suksta N, Cooley-Zgela T, Ramanand SG, Ahsan A, Nyati MK, Wright JJ, Van Waes C.

    Clin Cancer Res. 2011 Sep 1;17(17):5755-64. Epub 2011 Jul 12.

    PMID:
    21750205
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    XPF expression correlates with clinical outcome in squamous cell carcinoma of the head and neck.

    Vaezi A, Wang X, Buch S, Gooding W, Wang L, Seethala RR, Weaver DT, D'Andrea AD, Argiris A, Romkes M, Niedernhofer LJ, Grandis JR.

    Clin Cancer Res. 2011 Aug 15;17(16):5513-22. doi: 10.1158/1078-0432.CCR-11-0086. Epub 2011 Jul 7.

    PMID:
    21737503
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk